RALGPS1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.490200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.183760E-01
Normal-vs-Stage2
7.537600E-01
Normal-vs-Stage3
1.485230E-01
Normal-vs-Stage4
3.999200E-01
Stage1-vs-Stage2
6.686000E-02
Stage1-vs-Stage3
6.029800E-02
Stage1-vs-Stage4
3.965200E-01
Stage2-vs-Stage3
2.085600E-01
Stage2-vs-Stage4
7.311600E-01
Stage3-vs-Stage4
7.943500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.021900E-02
Normal-vs-AfricanAmerican
7.046600E-01
Normal-vs-Asian
4.184000E-01
Caucasian-vs-AfricanAmerican
7.398000E-01
Caucasian-vs-Asian
8.219400E-01
AfricanAmerican-vs-Asian
4.999200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.832100E-02
Normal-vs-Female
7.675600E-01
Male-vs-Female
2.712600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.536200E-01
Normal-vs-Age(41-60Yrs)
3.398100E-02
Normal-vs-Age(61-80Yrs)
1.775360E-01
Normal-vs-Age(81-100Yrs)
8.164200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.798600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.952250E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.080000E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.353200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.647800E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.407400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.925800E-01
Normal-vs-Daily Drinker
1.831000E-01
Normal-vs-Weekly Drinker
5.427600E-01
Normal-vs-Occasional Drinker
2.101800E-01
Normal-vs-Social Drinker
2.069800E-01
Non Drinker-vs-Daily Drinker
3.401600E-01
Non Drinker-vs-Weekly Drinker
8.569600E-01
Non Drinker-vs-Occasional Drinker
4.347600E-01
Non Drinker-vs-Social Drinker
3.402200E-01
Daily Drinker-vs-Weekly Drinker
5.218000E-01
Daily Drinker-vs-Occasional Drinker
7.316400E-01
Daily Drinker-vs-Social Drinker
9.074000E-01
Weekly Drinker-vs-Occasional Drinker
6.618400E-01
Weekly Drinker-vs-Social Drinker
4.559400E-01
Occasional Drinker-vs-Social Drinker
6.421600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.546600E-01
Normal-vs-Grade 2
9.318200E-02
Normal-vs-Grade 3
4.178300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.155200E-01
Grade 1-vs-Grade 3
1.168170E-01
Grade 1-vs-Grade 4
2.546600E-01
Grade 2-vs-Grade 3
3.700800E-01
Grade 2-vs-Grade 4
9.318200E-02
Grade 3-vs-Grade 4
4.178300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.547400E-01
Normal-vs-NonDiabetic
3.248500E-02
Diabetic-vs-NonDiabetic
1.370240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.955000E-01
Normal-vs-NoPancreatitis
6.274300E-02
Pancreatitis-vs-NoPancreatitis
8.802000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.989600E-02
Normal-vs-N1
8.052400E-01
N0-vs-N1
8.870300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.810430E-01
Normal-vs-TP53-NonMutant
1.306210E-02
TP53-Mutant-vs-TP53-NonMutant
1.131390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
